Katsu Takahashi

Dr. Katsu Takahashi is an oral surgeon at Kitano Hospital in Osaka, Japan, who is leading groundbreaking research on the regeneration of human teeth. His work with Toreghem Biopharma has revealed the presence of dormant tooth buds in the jaw, potentially allowing for the growth of a third set of teeth through the use of monoclonal antibodies. This innovative approach aims to not only replace lost teeth naturally but also address congenital conditions like anodontia. Takahashi's research journey began in the 1990s, achieving significant milestones in animal studies before advancing to human trials in 2024.